Cardiol Therapeutics (CRDL) Stock Price, News & Analysis

Company Overview

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.

Key Stats

• Today's Range: C$1.76 to C$1.85
• 50-Day Range: C$1.29 to C$2.23
• 52-Week Range: C$1.23 to C$2.33
• Volume: 46,153 shs
• Average Volume: 118,570 shs
• Market Capitalization: C$201.02 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CRDL Stock Analysis - Frequently Asked Questions

How have CRDL shares performed this year?

Cardiol Therapeutics' stock was trading at C$1.31 at the start of the year. Since then, CRDL stock has increased by 37.4% and is now trading at C$1.80.

How were Cardiol Therapeutics' earnings last quarter?

Cardiol Therapeutics Inc. (TSE:CRDL) released its quarterly earnings data on Tuesday, March, 31st. The company reported ($0.07) EPS for the quarter.

How do I buy shares of Cardiol Therapeutics?

Shares of CRDL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Cardiol Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiol Therapeutics investors own include Cardiol Therapeutics (CRTPF), Rolls-Royce Holdings plc (RR.L), Very Good Food (VRYYF), Gilead Sciences (GILD), Luminar Technologies (LAZR) and Meta Platforms (META).

Company Calendar

• Last Earnings: 3/31/2026
• Today: 5/05/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: TSE:CRDL
• CIK: N/A
• Web: www.cardiolrx.com
• Phone: 289 910 0850
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.39)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$42.93 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -238.02%
• Return on Assets: -54.15%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 4.16
• Quick Ratio: 6.84

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: C$1.83 per share
• Price / Cash Flow: 0.98
• Book Value: C$0.18 per share
• Price / Book: 10.09

Miscellaneous

• Outstanding Shares: 111,680,000
• Free Float: N/A
• Market Cap: C$201.02 million
• Optionable: Not Optionable
• Beta: 0.10